Pitching Australian Financial Review Cancer Reporters: Vertical Press Strategy
The Australian Financial Review covers cancer as a business, policy and capital story — not a health-desk human-interest story. To land coverage, pitch the economics of oncology: funding, biotech, insurers, workforce and regulation.
This guide gives you the angles, names and protocol to reach Australian Financial Review Cancer reporters with precision and speed.
Editorial Scope: What Australian Financial Review Covers in Cancer#
The AFR treats cancer through a markets-and-policy lens. Expect coverage of biotech capital raises, PBAC and MSAC reimbursement decisions, private health insurance costs, hospital economics and research funding.
Consumer health tips and patient diaries rarely fit. Corporate strategy, sovereign capability in drug manufacturing and productivity costs of illness do.
| Factor | Recommended Strategy | What Gets Ignored |
|---|---|---|
| Story frame | Market, policy or capital angle | Personal patient journeys |
| Data | Cost curves, funding gaps, ASX filings | Anecdotal clinic stories |
| Sources | Executives, PBAC/regulators, economists | Celebrity ambassadors |
| Timing | Tied to results, Budget, PBAC cycles | Awareness-month calendars |
| Exclusivity | Offer first-look data or filings | Mass-distributed releases |
Identifying Active Writers on the Australian Financial Review Cancer Reporters List#
Your Australian Financial Review Cancer reporters list should start with two names from our directory: Clare Colley and David Rowe. Both operate across health policy, biotech and corporate news.
Map each pitch to the writer's recent bylines before sending. A reimbursement story goes to the policy writer; a Series B raise goes to the markets writer.
💡 Vertical Pro Tip: The AFR runs a small cancer cohort, so a misfired pitch burns a relationship fast. Read the last five bylines from each Australian Financial Review Cancer journalists contact before you hit send — relevance beats volume every time.
Angles & Data Points That Resonate With Australian Financial Review Cancer Journalists#
Lead with numbers the newsroom can't generate itself: trial cost per patient, out-of-pocket gaps, PBS listing delays, or biotech valuation swings. Proprietary data is your strongest currency.
Policy friction sells: workforce shortages in oncology, imaging waitlists, or insurance premium impacts of new therapies. Frame these as productivity and fiscal stories.
- Capital: ASX-listed oncology biotech raising, licensing or trial results.
- Reimbursement: PBAC/MSAC decisions and their budget impact.
- Insurance: Private health premium pressure from cancer care costs.
- Sovereignty: Local manufacturing of cancer drugs and supply-chain risk.
- Workforce: Oncologist and radiologist shortages as an economic drag.
Outreach Protocols & Accessing Australian Financial Review Cancer Journalists Contacts#
Email is the default channel; keep the pitch to five lines with the hook, the data and your availability. Attach nothing on first contact — offer the dataset or interview instead.
For Australian Financial Review Cancer journalists contacts, verify addresses via byline pages, LinkedIn or the AFR newsroom switch. Never blast both reporters with identical copy.
- Pitch Tuesday to Thursday, early morning AEST.
- Subject line: the finding, not the announcement.
- Offer an exclusive window of 24–48 hours.
- Have an executive and a data source ready same-day.
Fast-Action Pitch Checklist for Cancer#
Run this checklist before every send to Australian Financial Review Cancer reporters. It takes two minutes and protects your hit rate.
- Is the angle financial, policy or capital — not clinical?
- Does the subject line carry a number or a decision?
- Is the pitch under 150 words with a clear ask?
- Have you matched the writer to the beat?
- Is proprietary data or a first-look offer included?
- Are spokespeople briefed and available within 24 hours?
- Is there a news hook — results, Budget, PBAC, filing?
Consistency wins this beat. Track responses, refine the Australian Financial Review Cancer reporters list quarterly, and treat each pitch as a relationship deposit rather than a transaction.